| 1 |
31571932 | Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial. | 2019 |
2 |
| 2 |
28926855 | A Comparison of the Efficacy of Once-Daily Fluticasone Furoate/Vilanterole with Twice-Daily Fluticasone Propionate/Salmeterol in Elderly Asthmatics. | 2018 Jan |
2 |
| 3 |
30215289 | Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma. | 2018 Jan-Dec |
1 |
| 4 |
26668137 | The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience. | 2016 Feb |
1 |
| 5 |
26730183 | Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk. | 2016 |
1 |
| 6 |
27965772 | Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy. | 2016 |
1 |
| 7 |
25849223 | Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy. | 2015 Feb 15 |
2 |
| 8 |
26704701 | Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials. | 2015 Dec 24 |
1 |
| 9 |
24114969 | A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD. | 2014 Mar |
1 |
| 10 |
25074268 | Fluticasone furoate/vilanterol: a review of its use in chronic obstructive pulmonary disease. | 2014 Sep |
1 |
| 11 |
23352226 | A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD. | 2013 Apr |
1 |
| 12 |
23578031 | Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study. | 2013 Oct |
1 |